Active Ingredient: Noradrenaline
Noradrenaline is indicated in adults weighing over 50kg for the on-going treatment of hypotensive emergencies with escalating noradrenaline dose requirements.
For this indication, competent medicine agencies globally authorize below treatments:
Intravenous
0.05 - 1.5 ug per kg of body weight
From 0.05 To 1.5 ug per kg of body weight once every day
Noradrenaline 0.08mg/ml solution for infusion should not be used for initiating vasopressor treatment. It may be considered for use in patients already established on noradrenaline therapy whose dose requirements are clinically confirmed to be escalating, such that Noradrenaline 0.08 mg/ml, solution for infusion may be commenced at a flow rate of 2 ml/hr.
Noradrenaline should only be administered as an intravenous infusion via a central venous catheter to minimize the risk of extravasation and subsequent tissue necrosis. Noradrenaline (norepinephrine) 0.08 mg/ml, solution for infusion should be infused at a controlled rate using a syringe driver pump.
Noradrenaline 0.08 mg/ml, solution for infusion should not be diluted before use: it is supplied ready to use. It should not be mixed with other medicines.
Blood pressure control: Blood pressure should be monitored carefully for the duration of therapy, and preferably controlled by arterial blood pressure monitoring. The patient should be monitored carefully for the duration of noradrenaline therapy.
The initial dose of noradrenaline base is usually between 0.05 and 0.15 micrograms/kg/min.
The recommended maintenance range of noradrenaline base is between 0.05 and 1.5 micrograms/kg/min.
Noradrenaline (Norepinephrine) 0.08 mg/ml, solution for infusion, should be used with a suitable syringe driver pump capable of accurately and consistently delivering the minimum specified volume at a strictly controlled rate of infusion in line with the dose titration instructions.
Once an infusion of noradrenaline has been established the dose should be titrated in steps of 0.05-0.1 micrograms/kg/min of noradrenaline base according to the pressor effect observed. There is great individual variation in the dose required to attain and maintain normotension. The aim should be to establish a low normal systolic blood pressure (100-120 mmHg) or to achieve an adequate mean arterial blood pressure (greater than 65 mmHg – depending on the patient’s condition).
Manual bolus for priming when initiating an infusion is not recommended.
Caution is required during syringe relay to avoid haemodynamic instability. Continuous noradrenaline infusion through a double pump system and an extension set reducing dead-space volume should be encouraged.
| Patient’s Weight (kg) | Posology (µg/kg/min) noradrenaline base | Posology (mg/h) noradrenaline base | Infusion rate (ml/h) |
|---|---|---|---|
| 50 | 0.05 | 0.15 | 1,9 |
| 0.1 | 0.3 | 3,8 | |
| 0.25 | 0.75 | 9,4 | |
| 0.5 | 1.5 | 18,8 | |
| 1 | 3 | 37,5 | |
| 1.5 | 4.5 | 56,3 | |
| <>60 | 0.05 | 0.18 | 2,3 |
| 0.1 | 0.36 | 4,5 | |
| 0.25 | 0.9 | 11,3 | |
| 0.5 | 1.8 | 22,5 | |
| 1 | 3.6 | 45,0 | |
| 1.5 | 5.4 | 67,5 | |
| 70 | 0.05 | 0.21 | 2,6 |
| 0.1 | 0.42 | 5,3 | |
| 0.25 | 1.05 | 13,1 | |
| 0.5 | 2.1 | 26,3 | |
| 1 | 4.2 | 52,5 | |
| 1.5 | 6.3 | 78,8 | |
| 80 | 0.05 | 0.24 | 3,0 |
| 0.1 | 0.48 | 6,0 | |
| 0.25 | 1.2 | 15,0 | |
| 0.5 | 2.4 | 30,0 | |
| 1 | 4.8 | 60,0 | |
| 1.5 | 7.2 | 90,0 | |
| 90 | 0.05 | 0.27 | 3,4 |
| 0.1 | 0.54 | 6,8 | |
| 0.25 | 1.35 | 16,9 | |
| 0.5 | 2.7 | 33,8 | |
| 1 | 5.4 | 67,5 | |
| 1.5 | 8.1 | 101,3 | |
| 100 | 0.05 | 0.3 | 3,8 |
| 0.1 | 0.6 | 7,5 | |
| 0.25 | 1.5 | 18,8 | |
| 0.5 | 3 | 37,5 | |
| 1 | 6 | 75,0 | |
| 1.5 | 9 | 112,5 |
h: hour
Noradrenaline 0.08mg/ml, solution for infusion should be continued until high-dose vasoactive drug support is no longer indicated, at which point, the infusion should be gradually decreased, then switched to an infusion of lower concentration. Abrupt withdrawal can result in acute hypotension.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
